| Market revenue in 2025 | USD 4.9 million |
| Market revenue in 2033 | USD 8.8 million |
| Growth rate | 7.66% (CAGR from 2026 to 2033) |
| Largest segment | Hsv-1/hsv-2 combines |
| Fastest growing segment | HSV-1/HSV-2 Combines |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | HSV-1/HSV-2 Combines, HSV-1, HSV-2 |
| Key market players worldwide | F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific Inc, Becton Dickinson & Co, Bio-Rad Laboratories Inc, BioMerieux SA, Diasorin SpA, Hologic Inc, Cepheid, QuidelOrtho Corp |
Publish Date: Jul 07, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Hologic Inc | View profile | 6,990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | www.hologic.com |
| Diasorin SpA | View profile | 3,233 | Via Crescentino Snc, Saluggia, Vercelli, Italy, 13040 | www.diasoringroup.com |
| Cepheid | View profile | 1001-5000 | Sunnyvale, California, United States, North America | www.cepheid.com |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Abbott | View profile | - | - | - |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to HSV Testing Market Outlook will help companies and investors design strategic landscapes.
Hsv-1/Hsv-2 Combines was the largest segment with a revenue share of 53.06% in 2025.
Horizon Databook has segmented the Australia hsv testing market based on hsv-1/hsv-2 combines, hsv-1, hsv-2 covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia HSV Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia HSV Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.